AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
GENE-THERAPY FOR HIV-INFECTION
Authors: CHADWICK DR LEVER AML
Citation: Dr. Chadwick et Aml. Lever, GENE-THERAPY FOR HIV-INFECTION, Expert opinion on therapeutic patents, 8(8), 1998, pp. 983-990
PAUSING OF REVERSE-TRANSCRIPTASE ON RETROVIRAL RNA TEMPLATES IS INFLUENCED BY SECONDARY STRUCTURES BOTH 5' AND 3' OF THE CATALYTIC SITE
Authors: HARRISON GP MAYO MS HUNTER E LEVER AML
Citation: Gp. Harrison et al., PAUSING OF REVERSE-TRANSCRIPTASE ON RETROVIRAL RNA TEMPLATES IS INFLUENCED BY SECONDARY STRUCTURES BOTH 5' AND 3' OF THE CATALYTIC SITE, Nucleic acids research, 26(14), 1998, pp. 3433-3442
NONRECIPROCAL PACKAGING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 RNA - A POSSIBLE ROLE FOR THE P2 DOMAIN OF GAG IN RNA ENCAPSIDATION
Authors: KAYE JF LEVER AML
Citation: Jf. Kaye et Aml. Lever, NONRECIPROCAL PACKAGING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 RNA - A POSSIBLE ROLE FOR THE P2 DOMAIN OF GAG IN RNA ENCAPSIDATION, Journal of virology, 72(7), 1998, pp. 5877-5885
FUNCTIONAL-ANALYSIS OF THE CORE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PACKAGING SIGNAL IN A PERMISSIVE CELL-LINE
Authors: HARRISON GP MIELE G HUNTER E LEVER AML
Citation: Gp. Harrison et al., FUNCTIONAL-ANALYSIS OF THE CORE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PACKAGING SIGNAL IN A PERMISSIVE CELL-LINE, Journal of virology, 72(7), 1998, pp. 5886-5896
DEVELOPMENT OF CELL-LINES STABLY EXPRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEINS FOR STUDIES IN ENCAPSIDATION AND GENE-TRANSFER
Authors: HASELHORST D KAYE JF LEVER AML
Citation: D. Haselhorst et al., DEVELOPMENT OF CELL-LINES STABLY EXPRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEINS FOR STUDIES IN ENCAPSIDATION AND GENE-TRANSFER, Journal of General Virology, 79, 1998, pp. 231-237
DEVELOPMENT OF AUTOANTIBODIES AND FACTOR-VIII INHIBITOR IN AN HIV-INFECTED HEMOPHILIAC FOLLOWING TREATMENT WITH COMBINATION ANTIRETROVIRAL THERAPY
Authors: EVANS GD MENDELSON GMS LEVER AML BAGLIN TP
Citation: Gd. Evans et al., DEVELOPMENT OF AUTOANTIBODIES AND FACTOR-VIII INHIBITOR IN AN HIV-INFECTED HEMOPHILIAC FOLLOWING TREATMENT WITH COMBINATION ANTIRETROVIRAL THERAPY, British Journal of Haematology, 102(5), 1998, pp. 1382-1383
EFFECTS OF CATION SUBSTITUTIONS ON REVERSE-TRANSCRIPTASE AND ON HUMAN-IMMUNODEFICIENCY-VIRUS PRODUCTION
Authors: FILLER AG LEVER AML
Citation: Ag. Filler et Aml. Lever, EFFECTS OF CATION SUBSTITUTIONS ON REVERSE-TRANSCRIPTASE AND ON HUMAN-IMMUNODEFICIENCY-VIRUS PRODUCTION, AIDS research and human retroviruses, 13(4), 1997, pp. 291-299
HIV GENETIC-VARIATION - CLINICAL IMPORTANCE
Authors: LEVER AML
Citation: Aml. Lever, HIV GENETIC-VARIATION - CLINICAL IMPORTANCE, The Journal of infection, 34(3), 1997, pp. 195-199
VARIABLE IMMORTALIZING POTENTIAL AND FREQUENT VIRUS LATENCY IN BLOOD-DERIVED T-CELL CLONES INFECTED WITH HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I
Authors: RICHARDSON JH HOLLSBERG P WINDHAGEN A CHILD LA HAFLER DA LEVER AML
Citation: Jh. Richardson et al., VARIABLE IMMORTALIZING POTENTIAL AND FREQUENT VIRUS LATENCY IN BLOOD-DERIVED T-CELL CLONES INFECTED WITH HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I, Blood, 89(9), 1997, pp. 3303-3314
GENE-THERAPY IN THE FIGHT AGAINST AIDS
Authors: LEVER AML
Citation: Aml. Lever, GENE-THERAPY IN THE FIGHT AGAINST AIDS, Expert opinion on therapeutic patents, 6(2), 1996, pp. 161-167
HIV AND OTHER LENTIVIRUS-BASED VECTORS
Authors: LEVER AML
Citation: Aml. Lever, HIV AND OTHER LENTIVIRUS-BASED VECTORS, Gene therapy, 3(6), 1996, pp. 470-471
EXPRESSION OF MUTANT AND WILD-TYPE GAG PROTEINS FOR GENE-THERAPY IN HIV-1 INFECTION
Authors: MIELE G LEVER AML
Citation: G. Miele et Aml. Lever, EXPRESSION OF MUTANT AND WILD-TYPE GAG PROTEINS FOR GENE-THERAPY IN HIV-1 INFECTION, Gene therapy, 3(4), 1996, pp. 357-361
SEQUENCES INVOLVED IN THE DIMERIZATION OF HUMAN T-CELL LEUKEMIA-VIRUSTYPE-1 RNA
Authors: GREATOREX JS LAISSE V DOKHELAR MC LEVER AML
Citation: Js. Greatorex et al., SEQUENCES INVOLVED IN THE DIMERIZATION OF HUMAN T-CELL LEUKEMIA-VIRUSTYPE-1 RNA, Nucleic acids research, 24(15), 1996, pp. 2919-2923
NEISSERIAL DISEASE
Authors: RICHARDSON MP LEVER AML
Citation: Mp. Richardson et Aml. Lever, NEISSERIAL DISEASE, The Journal of infection, 32(2), 1996, pp. 175-176
REASONS FOR DELAY IN ADMINISTRATION OF ANTIBIOTICS TO PATIENTS WITH MENINGITIS AND MENINGOCOCCEMIA
Authors: WILKS D LEVER AML
Citation: D. Wilks et Aml. Lever, REASONS FOR DELAY IN ADMINISTRATION OF ANTIBIOTICS TO PATIENTS WITH MENINGITIS AND MENINGOCOCCEMIA, The Journal of infection, 32(1), 1996, pp. 49-51
TRANS-ACTING PROTEINS INVOLVED IN RNA ENCAPSIDATION AND VIRAL ASSEMBLY IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: KAYE JF LEVER AML
Citation: Jf. Kaye et Aml. Lever, TRANS-ACTING PROTEINS INVOLVED IN RNA ENCAPSIDATION AND VIRAL ASSEMBLY IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virology, 70(2), 1996, pp. 880-886
THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 5'-PACKAGING SIGNAL STRUCTUREAFFECTS TRANSLATION BUT DOES NOT FUNCTION AS AN INTERNAL RIBOSOME ENTRY SITE STRUCTURE
Authors: MIELE G MOULAND A HARRISON GP COHEN E LEVER AML
Citation: G. Miele et al., THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 5'-PACKAGING SIGNAL STRUCTUREAFFECTS TRANSLATION BUT DOES NOT FUNCTION AS AN INTERNAL RIBOSOME ENTRY SITE STRUCTURE, Journal of virology, 70(2), 1996, pp. 944-951
SURVIVAL AFTER AORTIC DISSECTION IN GIANT-CELL ARTERITIS
Authors: RICHARDSON MP LEVER AML FINK AM DIXON AK HAZLEMAN BL
Citation: Mp. Richardson et al., SURVIVAL AFTER AORTIC DISSECTION IN GIANT-CELL ARTERITIS, Annals of the Rheumatic Diseases, 55(5), 1996, pp. 332-333
SEQUENCES INVOLVED IN DIMER FORMATION OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 RNA
Authors: GREATOREX JS LAISSE V DOKHELAR MC LEVER AML
Citation: Js. Greatorex et al., SEQUENCES INVOLVED IN DIMER FORMATION OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 RNA, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 18-18
TAX GENE ANALYSIS IN HUMAN T-CELL LEUKEMIA-VIRUS TYPE I-INFECTED T-CELL CLONES DISPLAYING PHENOTYPIC VARIATION
Authors: ROSE NJ RICHARDSON J DESSELBERGER U LEVER AML
Citation: Nj. Rose et al., TAX GENE ANALYSIS IN HUMAN T-CELL LEUKEMIA-VIRUS TYPE I-INFECTED T-CELL CLONES DISPLAYING PHENOTYPIC VARIATION, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 147-147
MASON-PFIZER MONKEY VIRUS (MPMV) AS A VECTOR FOR HUMAN GENE-THERAPY
Authors: GUESDON FMJ RHEE S HUNTER E LEVER AML
Citation: Fmj. Guesdon et al., MASON-PFIZER MONKEY VIRUS (MPMV) AS A VECTOR FOR HUMAN GENE-THERAPY, Journal of cellular biochemistry, 1995, pp. 407-407
ABSENCE OF EXOGENOUS RETROVIRUSES IN FELTYS-SYNDROME
Authors: NELSON PN BOWMAN SJ HAY FC LANCHBURY JS PANAYI GS LEVER AML
Citation: Pn. Nelson et al., ABSENCE OF EXOGENOUS RETROVIRUSES IN FELTYS-SYNDROME, British journal of rheumatology, 34(2), 1995, pp. 185-187
TREATMENT OF NATIVE VALVE CANDIDA ENDOCARDITIS WITH FLUCONAZOLE
Authors: WELLS CJ LEECH GJ LEVER AML WANSBROUGHJONES MH
Citation: Cj. Wells et al., TREATMENT OF NATIVE VALVE CANDIDA ENDOCARDITIS WITH FLUCONAZOLE, The Journal of infection, 31(3), 1995, pp. 233-235
SECONDARY STRUCTURE MODEL OF THE MASON-PFIZER MONKEY VIRUS 5' LEADER SEQUENCE - IDENTIFICATION OF A STRUCTURAL MOTIF COMMON TO A VARIETY OFRETROVIRUSES
Authors: HARRISON GP HUNTER E LEVER AML
Citation: Gp. Harrison et al., SECONDARY STRUCTURE MODEL OF THE MASON-PFIZER MONKEY VIRUS 5' LEADER SEQUENCE - IDENTIFICATION OF A STRUCTURAL MOTIF COMMON TO A VARIETY OFRETROVIRUSES, Journal of virology, 69(4), 1995, pp. 2175-2186
CIS-ACTING SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA PACKAGING
Authors: KAYE JF RICHARDSON JH LEVER AML
Citation: Jf. Kaye et al., CIS-ACTING SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA PACKAGING, Journal of virology, 69(10), 1995, pp. 6588-6592
Risultati: 1-25 | 26-37